Neuroscience
Not only can cognitive behavioural therapy (CBT) provide sufferers of schizophrenia with additional benefits above and beyond those gained from taking anti-psychotic medication, but some of these benefits continue to persist two years later. Furthermore, the extra expense of providing cognitive behavioural therapy to these patients is offset by money saved from the patients spending less time in hospital.
Mike Startup (University of Newcastle, Australia) and colleagues at the University of Wales, UK, recruited 90 patients with schizophrenia spectrum disorder who had been admitted to hospital suffering from an acute episode of psychosis. Forty-three of them were given treatment-as-usual, which included anti-psychotic medication and nursing care. Forty-seven of them were additionally given up to 25 90-minute sessions of CBT provided by one of three clinical psychologists.
A previous study found that a year after their hospital admission, those patients given CBT on top of treatment-as-usual had fewer positive symptoms (hallucinations and delusions), fewer negative symptoms (for example apathy and lack of emotion) and better social functioning. Now Startup’s team have managed to test 73 per cent of the original sample two years after their hospital admission, and they’ve found that the CBT group still enjoy fewer negative symptoms and better social functioning than the treatment-as-usual group. Moreover, they estimated that the extra cost of providing CBT (average of £769 per patient over the two years) was compensated by savings gained by the CBT patients tending to spend less time in hospital (estimated £2704 average saving per patient).
“CBT for patients with schizophrenia who have been admitted to hospital as a result of an acute psychotic episode is likely to be no more expensive than routine care, but should secure for those patients advantages in terms of negative symptoms and social functioning which persist for at least two years”, the researchers concluded.
__________________________________
Startup, M., Jackson, M.C., Evans, K.E. & Bendix, S. (2005). North Wales randomised controlled trial of cognitive behaviour therapy for acute schizophrenia spectrum disorders: two-year follow-up and economic evaluation.Psychological Medicine, 35, 1307-1316.
Post written by Christian Jarrett (@psych_writer) for the BPS Research Digest.
- No Schizophrenia?
2 NAMES, 1 DISEASE: Does schizophrenia=psychotic bipolar disorder? in Current Psychiatry suggests that schizophrenia is actually severe bipolar I psychosis and not a separate diagnosis. A comprehensive review references questions going back many years,...
- Treating Schizophrenia Without Drugs
There's no doubt the discovery of anti-psychotic drugs was a breakthrough. Previously people with schizophrenia could expect hospital confinement and little in the way of actual treatment. Today's anti-psychotics are safer than the early versions,...
- Who Will Behave Violently In The Next Two Years?
Psychologists and psychiatrists often get the blame on the rare occasions that a former mental health patient goes on to commit a violent act (see note below). They are expected to be able to predict which patients are a risk. But a new American study...
- Neuropsychology Abstract Of The Day: Schizophrenia
Barrera A, McKenna PJ, & Berrios GE. Two new scales of formal thought disorder in schizophrenia. Psychiatry Research. 2007 Nov 6; [Epub ahead of print] Warneford Hospital, Oxford, OX3 7JX, UK. Information provided by patients and respective carers may...
- Risperdal (risperidone) And Pediatric Schizophrenia And Bipolar Disorder
An FDA press release from yesterday: FDA Approves Risperdal for Two Psychiatric Conditions in Children and Adolescents The U.S. Food and Drug Administration today approved Risperdal (risperidone) for the treatment of schizophrenia in adolescents, ages...
Neuroscience
The long-term benefits of CBT for schizophrenia
Not only can cognitive behavioural therapy (CBT) provide sufferers of schizophrenia with additional benefits above and beyond those gained from taking anti-psychotic medication, but some of these benefits continue to persist two years later. Furthermore, the extra expense of providing cognitive behavioural therapy to these patients is offset by money saved from the patients spending less time in hospital.
Mike Startup (University of Newcastle, Australia) and colleagues at the University of Wales, UK, recruited 90 patients with schizophrenia spectrum disorder who had been admitted to hospital suffering from an acute episode of psychosis. Forty-three of them were given treatment-as-usual, which included anti-psychotic medication and nursing care. Forty-seven of them were additionally given up to 25 90-minute sessions of CBT provided by one of three clinical psychologists.
A previous study found that a year after their hospital admission, those patients given CBT on top of treatment-as-usual had fewer positive symptoms (hallucinations and delusions), fewer negative symptoms (for example apathy and lack of emotion) and better social functioning. Now Startup’s team have managed to test 73 per cent of the original sample two years after their hospital admission, and they’ve found that the CBT group still enjoy fewer negative symptoms and better social functioning than the treatment-as-usual group. Moreover, they estimated that the extra cost of providing CBT (average of £769 per patient over the two years) was compensated by savings gained by the CBT patients tending to spend less time in hospital (estimated £2704 average saving per patient).
“CBT for patients with schizophrenia who have been admitted to hospital as a result of an acute psychotic episode is likely to be no more expensive than routine care, but should secure for those patients advantages in terms of negative symptoms and social functioning which persist for at least two years”, the researchers concluded.
__________________________________
Startup, M., Jackson, M.C., Evans, K.E. & Bendix, S. (2005). North Wales randomised controlled trial of cognitive behaviour therapy for acute schizophrenia spectrum disorders: two-year follow-up and economic evaluation.Psychological Medicine, 35, 1307-1316.
Post written by Christian Jarrett (@psych_writer) for the BPS Research Digest.
- No Schizophrenia?
2 NAMES, 1 DISEASE: Does schizophrenia=psychotic bipolar disorder? in Current Psychiatry suggests that schizophrenia is actually severe bipolar I psychosis and not a separate diagnosis. A comprehensive review references questions going back many years,...
- Treating Schizophrenia Without Drugs
There's no doubt the discovery of anti-psychotic drugs was a breakthrough. Previously people with schizophrenia could expect hospital confinement and little in the way of actual treatment. Today's anti-psychotics are safer than the early versions,...
- Who Will Behave Violently In The Next Two Years?
Psychologists and psychiatrists often get the blame on the rare occasions that a former mental health patient goes on to commit a violent act (see note below). They are expected to be able to predict which patients are a risk. But a new American study...
- Neuropsychology Abstract Of The Day: Schizophrenia
Barrera A, McKenna PJ, & Berrios GE. Two new scales of formal thought disorder in schizophrenia. Psychiatry Research. 2007 Nov 6; [Epub ahead of print] Warneford Hospital, Oxford, OX3 7JX, UK. Information provided by patients and respective carers may...
- Risperdal (risperidone) And Pediatric Schizophrenia And Bipolar Disorder
An FDA press release from yesterday: FDA Approves Risperdal for Two Psychiatric Conditions in Children and Adolescents The U.S. Food and Drug Administration today approved Risperdal (risperidone) for the treatment of schizophrenia in adolescents, ages...